University of California Center for Accelerated Innovation

Improving outcomes for patients with heart, lung and blood diseases

With support from the National Heart, Lung, and Blood Institute (NHLBI), the UC CAI advances early-stage drugs, devices and diagnostics toward commercialization to benefit patients with heart, lung and blood diseases.

Innovators receive pilot funds, mentorship and project-management support to develop their technologies. UC CAI is part of a prestigious, national consortium of academic innovators that includes Harvard University and Cleveland Clinic.


Click the links below to contact your Research Navigator.

Join our Mailing List